NDC product
Budesonide
NDC 0536-1112 · Rugby Laboratories
Key facts
| Product NDC | 0536-1112 |
|---|---|
| Proprietary name | Budesonide |
| Nonproprietary name | Budesonide |
| Substances | BUDESONIDE |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Labeler | Rugby Laboratories |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA078949 |
| Pharmacologic classes | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| Marketing start | Jul 27, 2016 |
| Marketing end | Jun 30, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory